Home/Filings/4/0001493152-20-013026
4//SEC Filing

Cremisi Henry D. 4

Accession 0001493152-20-013026

CIK 0000027367other

Filed

Jul 8, 8:00 PM ET

Accepted

Jul 9, 7:58 PM ET

Size

7.7 KB

Accession

0001493152-20-013026

Insider Transaction Report

Form 4
Period: 2020-06-25
Transactions
  • Award

    STOCK OPTION (right to buy)

    2020-06-25+18,00018,000 total
    Exercise: $13.94From: 2020-06-25Exp: 2025-06-04COMMON STOCK (18,000 underlying)
  • Award

    STOCK OPTION (right to buy)

    2020-06-25+2,0002,000 total
    Exercise: $13.48Exp: 2025-06-25COMMON STOCK (2,000 underlying)
Footnotes (2)
  • [F1]Stock options were granted June 4, 2020 contingent upon the approval by Daxor Corporation shareholders of the Daxor Corporation 2020 Incentive Compensation plan (the "Plan") at the 2020 annual meeting of shareholders held on June 25, 2020. The plan was approved by the Daxor Corporation shareholders.
  • [F2]The stock options will vest in three installments June 25, 2021 (667) June 25, 2022 (667) and June 25, 2023 (666)

Documents

1 file

Issuer

DAXOR CORP

CIK 0000027367

Entity typeother

Related Parties

1
  • filerCIK 0001816592

Filing Metadata

Form type
4
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 7:58 PM ET
Size
7.7 KB